Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of …

NM Muñoz, AA Minhaj, KL Maldonado… - Magnetic Resonance …, 2019 - Elsevier
Objectives To compare the accuracy of contrast-enhanced ultrasound (CEUS) and Dynamic
contrast-enhanced (DCE) magnetic resonance imaging (MRI) for the assessment of …

[HTML][HTML] Therapeutic evaluation of sorafenib for hepatocellular carcinoma using contrast‑enhanced ultrasonography: Preliminary result

K Shiozawa, M Watanabe, T Ikehara… - Oncology …, 2016 - spandidos-publications.com
The present study aimed to determine the usefulness of contrast-enhanced ultrasonography
(CEUS) with Sonazoid in evaluating the therapeutic response to sorafenib for hepatocellular …

[HTML][HTML] Comparison of vascularity observed using contrast-enhanced 3D ultrasonography and pathological changes in patients with hepatocellular carcinoma after …

H Fukuda, K Numata, K Hara, A Nozaki… - Journal of …, 2018 - ncbi.nlm.nih.gov
Aim: The aim of this study was to compare vascularity observed using contrast-enhanced 3D
ultrasonography and pathological changes in human hepatocellular carcinoma (HCC) and …

Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma

M Baron Toaldo, V Salvatore, S Marinelli… - Molecular imaging and …, 2015 - Springer
Purpose The aim of this study was to assess the early response to sorafenib using
ultrasound molecular imaging in a murine model of hepatocellular carcinoma (HCC) …

Early treatment response to sorafenib for rabbit VX2 orthotic liver tumors: evaluation by quantitative contrast-enhanced ultrasound

WT Kong, HX Yuan, H Cai, WP Wang, Y Tang… - Tumor Biology, 2015 - Springer
The aim of our study was to investigate the application of contrast-enhanced ultrasound
(CEUS) and its quantification analysis for the prediction of early treatment response of …

Multiparametric MR diffusion‐weighted imaging for monitoring the ultra‐early treatment effect of sorafenib in human hepatocellular carcinoma xenografts

X Chen, Z Ma, Y Huang, L He, C Liang… - Journal of Magnetic …, 2017 - Wiley Online Library
Purpose To investigate the value of multiparametric magnetic resonance imaging (MRI)
diffusion‐weighted imaging (DWI) for monitoring the ultra‐early (within 24 hours) treatment …

[HTML][HTML] Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study

K Shiozawa, M Watanabe, Y Kikuchi… - World Journal of …, 2012 - ncbi.nlm.nih.gov
AIM: To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …

Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results

C Schraml, NF Schwenzer… - American Journal of …, 2009 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to evaluate signal changes of advanced
hepatocellular carcinoma in diffusion-weighted MRI in the early-response monitoring of oral …

[HTML][HTML] Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib

JI Choi, DK Imagawa, P Bhosale… - Clinical and …, 2014 - ncbi.nlm.nih.gov
Hepatocellular carcinomas are highly vascular tumors, showing progressive
hypervascularity by the process of neoangiogenesis. Tumor angiogenesis is critical for …

Evaluation of antiangiogenic and antiproliferative effects of sorafenib by sequential histology and intravoxel incoherent motion diffusion‐weighted imaging in an …

S Yang, J Lin, F Lu, Z Han, C Fu, P Lv… - Journal of Magnetic …, 2017 - Wiley Online Library
Purpose To investigate the effectiveness of intravoxel incoherent motion (IVIM) in the
assessment of the therapeutic efficacy of sorafenib in an orthotopic hepatocellular …